DRAFT ONLY- DO NOT PUBLISH/DISTRIBUTE
Reimagining Neurology for the Challenges of 2026
By: Lennard M. Goetze, Ed.D
Dr.
Lombard’s career has been defined by an unwavering commitment to solving
complex neurological problems—particularly those that conventional medicine has
struggled to fully explain or treat. As 2026 approaches, his mission is
expanding even further: advancing research, developing new therapeutic
strategies, and building collaborative clinical models that address the root
causes of neurological disease.
A Career Shaped by Curiosity and
Clinical Experience
Dr.
Lombard’s journey into neurology was shaped by an unusually broad medical
foundation. Early in his career, he trained in both psychiatry and neurology, an experience that
profoundly influenced his clinical perspective. While he ultimately chose
neurology as his primary specialty, his psychiatric training instilled an enduring
appreciation for the emotional, behavioral, and psychological dimensions of
neurological illness.
His work later expanded into research and clinical care for amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease. Dr. Lombard’s insights into antioxidant systems and neurological dysfunction attracted national attention, including appearances on major media platforms discussing emerging research into ALS.
Over time, his practice evolved into a unique clinical environment in which he treated a wide spectrum of neurological conditions—from hyperactive autistic children to patients with advanced ALS. The diversity of these cases provided a rare window into how different neurological disorders often share overlapping biological pathways.
Dr.
Lombard also served in leadership roles in academic medicine, including
positions as:
·
Chief of
Neurology at
·
Chief of
Neurology at
·
Clinical Assistant Professor at
These experiences exposed him to
both acute neurological crises and chronic neurodegenerative diseases, shaping
the integrative approach he now champions.
A
Pioneer in Genomic Psychiatry
Dr. Lombard’s curiosity about the biological drivers of neurological and psychiatric illness eventually led him into the world of biotechnology.
Recognizing
the growing potential of genetics to guide treatment decisions, he founded Genomind, a company focused on using
genetic testing to inform psychiatric care. The company became one of the
earliest innovators in pharmacogenomic testing, helping clinicians better
understand how genetic variations influence medication responses in psychiatric
patients.
This work reinforced Dr. Lombard’s
belief that brain disorders cannot be
understood in isolation. Instead, they must be viewed through a
systems-based lens involving genetics, immune function, metabolism,
environmental exposures, and psychological stressors.
A
New Vision for Neurology
Today,
Dr. Lombard is pursuing what may be the most ambitious chapter of his career.
In
preparation for 2026, he is
focusing on two parallel missions:
1.
Advancing
research into neurodegenerative disease mechanisms
2.
Developing new
therapeutic strategies through biotechnology and integrative clinical care
One
area of particular focus is his research into the viral and immune-mediated origins of neurodegenerative diseases.
This
hypothesis challenges conventional models of neurological disease, but it
reflects a growing body of evidence linking immune dysfunction to brain
disorders. To pursue this line of investigation, Dr. Lombard is developing a
biotechnology initiative focused on drug
discovery and repurposing FDA-approved medications for neurological
protection and recovery.
The
“SIT Hypothesis” – A New Framework for Neurodegeneration
One
of Dr. Lombard’s most intriguing contributions is what he calls the SIT hypothesis, which identifies three
major drivers of neurodegenerative disease:
S – Sleep dysregulation
I – Infection and inflammation
T – Trauma
Trauma in this model includes both physical trauma (such as traumatic brain injury) and psychological trauma, both of which can trigger long-term neurological consequences. According to Dr. Lombard, these factors interact to create a cumulative burden on the nervous system. Over time, this burden may contribute to disorders such as Parkinson’s disease, ALS, and cognitive decline.
His
current research explores how addressing these underlying drivers may prevent
or slow neurological degeneration.
.jpg)
Addressing
the Most Critical Neurological Disorders of Our Time
.jpg)
Dr.
Lombard’s clinical interests span many of the most challenging neurological
conditions facing modern medicine, including:
·
ALS
(Amyotrophic Lateral Sclerosis)
·
Parkinson’s
disease
·
Alzheimer’s
disease and memory disorders
·
Early
onset motor neuron disease
·
Undiagnosed
neurological syndromes
·
Neurobehavioral
disorders
·
Mood and anxiety
disorders with neurological roots
·
Autism
spectrum disorders
What distinguishes his approach is
the recognition that many of these conditions are not isolated diseases, but rather overlapping syndromes
that share biological pathways. Traditional neurology often categorizes
patients strictly by diagnostic criteria. However, Dr. Lombard argues that real
patients rarely fit neatly into these categories.
Instead, he sees neurological
disorders as dimensional conditions—complex
networks of symptoms involving cognition, emotion, metabolism, immune function,
and environmental factors.
This
perspective is reshaping how he evaluates and treats patients.
The
Role of Environmental Factors and Neuroinflammation
Dr. Lombard has also become increasingly interested in how environmental exposures affect brain health. He notes that factors such as chronic infections, mold exposure, environmental toxins, and systemic inflammation may disrupt the blood–brain barrier, the protective interface that regulates what enters the brain.
When this barrier becomes
compromised, immune cells and inflammatory molecules may infiltrate the nervous
system, potentially triggering chronic neurological symptoms.
This
emerging area of research is influencing his integrative treatment strategies,
which often include metabolic, immunological, and environmental assessments.
.jpg)
Neuroplasticity
and the Brain’s Capacity to Heal
.jpg)
Another cornerstone of Dr. Lombard’s work is neuroplasticity, the brain’s remarkable ability to reorganize itself after injury or disease. Historically, neurologists believed that damaged neurons could not recover. Today, research shows that the brain can often compensate by rerouting functions through alternative neural pathways.
Dr. Lombard’s research explores
ways to stimulate these pathways through therapies that combine neurological
rehabilitation, metabolic support, and integrative treatments.
His
goal is not only to slow disease progression but also to restore functional capacity whenever possible.
A
Clinical Philosophy Built on Deep Listening
Despite his involvement in advanced research and biotechnology, Dr. Lombard maintains a deeply personal approach to patient care. He believes that many diagnoses emerge not from laboratory tests, but from carefully listening to the patient’s story.
His psychiatric training reinforced
the importance of this skill. In his experience, the most revealing clues about
a neurological condition often arise during the patient’s narrative rather than
during formal testing.
For
this reason, Dr. Lombard’s clinical model emphasizes extended consultations and
long-term relationships with patients.
A
New Model of Neurological Practice
Dr.
Lombard’s upcoming practice expansion in
This
model allows for:
·
Continuous physician access
·
Extended diagnostic evaluations
·
Integration of multiple medical disciplines
·
Personalized treatment strategies
For
many patients with difficult-to-diagnose neurological conditions, this level of
attention can make a transformative difference.
The
Power of Interdisciplinary Collaboration
Perhaps the most defining element of Dr. Lombard’s philosophy is his belief in interdisciplinary clinical collaboration. Neurological disorders rarely exist in isolation. They intersect with immunology, endocrinology, psychiatry, environmental medicine, and many other disciplines.
Dr. Lombard advocates for a return
to collaborative medicine, where physicians across specialties communicate
regularly to solve complex patient problems. In an age of hyper-specialization, he believes
the future lies in reconnecting these fragmented areas of expertise.
Looking
Ahead
As neurological disorders continue to increase worldwide, the need for new ideas and innovative clinical models has never been greater. Through his research, biotechnology initiatives, and integrative neurological practice, Dr. Jay Lombard is helping shape the next generation of brain health strategies.
His work reflects a central belief:
that solving the mysteries of neurological disease requires not only advanced
science, but also curiosity, collaboration, and the courage to challenge
established assumptions.
In 2026 and beyond, that philosophy
may prove essential in confronting the neurological challenges of our time.
